Topic List : Cancer
Tumor rejection requires coordinated immune response
Effective anti-tumor activity requires a systemic, rather than only a local, immune response at the tumor site. A Stanford study may help clinicians pinpoint why only some cancer patients respond to immunotherapies.
GPS for tracking immune cells
In the culmination of a 10-year-long effort, researchers have demonstrated the first visualization of human immune cells as they track down brain tumor cells in living patients.
Benefit shown in a subgroup of patients
Glioblastoma patients with a high degree of vascularization of their tumors were found to have benefited from a treatment previously deemed ineffective, a new Stanford study shows.
Blood test to evaluate lung cancer tumors
A technique developed at Stanford for detecting the genetic profiles of tumor cells sifted from the bloodstream could offer a valuable tool for the clinic and the lab.
Drug interactions that may reduce mortality
Stanford researchers found that certain drug combinations were associated with lower mortality rates among breast cancer patients, pointing to potential drug targets and new ways of thinking about known diseases.
Nusse wins $3 million Breakthrough Prize
The developmental biologist was honored for helping to decode how Wnt signaling proteins affect embryonic development, cancer and the activity of tissue-specific adult stem cells that repair damage after injury or disease.
Reducing tumor growth
Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.
Canine cancer immunotherapy
The work extends research by Stanford scientists who found that blocking CD47 might be useful in treating human cancer.
Tracking cancer evolution in the blood
Monitoring cancer DNA in blood can predict recurrence and prognosis and drive treatment decisions. A Stanford study of 92 lymphoma patients suggests similar techniques may work for other tumors.
Plans for the nation’s first hadron center for cancer therapy
Hadron therapy, which relies on beams of charged particles including protons and heavier ions such as carbon, is expected to increase cancer cure rates because it can be used to treat larger tumors or those resistant to conventional radiotherapy.